843 related articles for article (PubMed ID: 14971932)
21. Verification of the C-terminal intramolecular beta-sheet in Abeta42 aggregates using solid-state NMR: implications for potent neurotoxicity through the formation of radicals.
Masuda Y; Uemura S; Nakanishi A; Ohashi R; Takegoshi K; Shimizu T; Shirasawa T; Irie K
Bioorg Med Chem Lett; 2008 Jun; 18(11):3206-10. PubMed ID: 18468894
[TBL] [Abstract][Full Text] [Related]
22. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.
Terzi E; Hölzemann G; Seelig J
Biochemistry; 1997 Dec; 36(48):14845-52. PubMed ID: 9398206
[TBL] [Abstract][Full Text] [Related]
23. Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation.
Hou L; Lee HG; Han F; Tedesco JM; Perry G; Smith MA; Zagorski MG
J Alzheimers Dis; 2013; 37(1):9-18. PubMed ID: 23719512
[TBL] [Abstract][Full Text] [Related]
24. Probing the initial stage of aggregation of the Abeta(10-35)-protein: assessing the propensity for peptide dimerization.
Tarus B; Straub JE; Thirumalai D
J Mol Biol; 2005 Feb; 345(5):1141-56. PubMed ID: 15644211
[TBL] [Abstract][Full Text] [Related]
25. Thermodynamic analysis of the aggregation propensity of oxidized Alzheimer's beta-amyloid variants.
Hortschansky P; Christopeit T; Schroeckh V; Fändrich M
Protein Sci; 2005 Nov; 14(11):2915-8. PubMed ID: 16199659
[TBL] [Abstract][Full Text] [Related]
26. Influence of the solvent on the self-assembly of a modified amyloid beta peptide fragment. II. NMR and computer simulation investigation.
Hamley IW; Nutt DR; Brown GD; Miravet JF; Escuder B; Rodríguez-Llansola F
J Phys Chem B; 2010 Jan; 114(2):940-51. PubMed ID: 20039666
[TBL] [Abstract][Full Text] [Related]
27. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
Danielsson J; Pierattelli R; Banci L; Gräslund A
FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
[TBL] [Abstract][Full Text] [Related]
28. Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35.
Clementi ME; Marini S; Coletta M; Orsini F; Giardina B; Misiti F
FEBS Lett; 2005 May; 579(13):2913-8. PubMed ID: 15890345
[TBL] [Abstract][Full Text] [Related]
29. Oligomers of the prion protein fragment 106-126 are likely assembled from beta-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide's monomeric conformation.
Grabenauer M; Wu C; Soto P; Shea JE; Bowers MT
J Am Chem Soc; 2010 Jan; 132(2):532-9. PubMed ID: 20020713
[TBL] [Abstract][Full Text] [Related]
30. A molecular dynamics approach to the structural characterization of amyloid aggregation.
Cecchini M; Curcio R; Pappalardo M; Melki R; Caflisch A
J Mol Biol; 2006 Apr; 357(4):1306-21. PubMed ID: 16483608
[TBL] [Abstract][Full Text] [Related]
31. Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts.
Danielsson J; Jarvet J; Damberg P; Gräslund A
Biochemistry; 2004 May; 43(20):6261-9. PubMed ID: 15147210
[TBL] [Abstract][Full Text] [Related]
32. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation.
Johansson AS; Bergquist J; Volbracht C; Päiviö A; Leist M; Lannfelt L; Westlind-Danielsson A
Neuroreport; 2007 Apr; 18(6):559-63. PubMed ID: 17413657
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the Phe20 residue in Alzheimer's amyloid beta-peptide might decrease its toxicity due to disruption of the Met35-cupric site electron transfer pathway.
Pogocki D
Chem Res Toxicol; 2004 Mar; 17(3):325-9. PubMed ID: 15025502
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.
Whittemore NA; Mishra R; Kheterpal I; Williams AD; Wetzel R; Serpersu EH
Biochemistry; 2005 Mar; 44(11):4434-41. PubMed ID: 15766273
[TBL] [Abstract][Full Text] [Related]
35. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
Nagarajan S; Ramalingam K; Neelakanta Reddy P; Cereghetti DM; Padma Malar EJ; Rajadas J
FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
[TBL] [Abstract][Full Text] [Related]
36. Distance measurement between Tyr10 and Met35 in amyloid beta by site-directed spin-labeling ESR spectroscopy: implications for the stronger neurotoxicity of Abeta42 than Abeta40.
Murakami K; Hara H; Masuda Y; Ohigashi H; Irie K
Chembiochem; 2007 Dec; 8(18):2308-14. PubMed ID: 18022992
[TBL] [Abstract][Full Text] [Related]
37. Capturing intermediate structures of Alzheimer's beta-amyloid, Abeta(1-40), by solid-state NMR spectroscopy.
Chimon S; Ishii Y
J Am Chem Soc; 2005 Oct; 127(39):13472-3. PubMed ID: 16190691
[TBL] [Abstract][Full Text] [Related]
38. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Sciarretta KL; Boire A; Gordon DJ; Meredith SC
Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
[TBL] [Abstract][Full Text] [Related]
39. A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization.
Bitan G; Tarus B; Vollers SS; Lashuel HA; Condron MM; Straub JE; Teplow DB
J Am Chem Soc; 2003 Dec; 125(50):15359-65. PubMed ID: 14664580
[TBL] [Abstract][Full Text] [Related]
40. Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F).
Poulsen SA; Watson AA; Fairlie DP; Craik DJ
J Struct Biol; 2000 Jun; 130(2-3):142-52. PubMed ID: 10940222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
